Stiefel Extends PanOxyl Line With Former Rx Acne Washes
This article was originally published in The Rose Sheet
Executive Summary
Stiefel Laboratories extends its PanOxyl skin-care line with two previously Rx acne products that will debut over-the-counter this spring.
You may also be interested in...
FDA Tempers Benzoyl Peroxide's GRASE Status With Additional Warnings
FDA deems benzoyl peroxide an ingredient generally recognized as safe and effective (GRASE) for OTC topical acne drug products, providing that manufacturers add warnings and directions to product cartons
GSK Gains Foothold In U.S. Skin Care With Stiefel Deal
GlaxoSmithKline will more than double its dermatology sales to $1.5 billion with the acquisition of Stiefel Laboratories, a move that provides GSK a foothold in the U.S. market for nonprescription skin-care products
IFF Narrows Focus To Fragrance, Health, Food
International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value of $2.85bn to reduce debt and streamline its business to three segments, including scents.